Advaxis, Inc. Added to Stonegate’s Equity Research Universe

NORTH BRUNSWICK, N.J.--(BUSINESS WIRE)--Stonegate Securities has initiated research coverage on Advaxis, Inc., (OTCBB: ADXS) the live, attenuated Listeria monocytogenes (Lm) vaccine company, last week. For more information on the research report, please contact Marco Rodriguez, CFA of Stonegate Securities at marco@stonegateinc.com and/or your local investment professional.
MORE ON THIS TOPIC